Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of sinoporphyrin sodium photodynamic therapy laser condition optimization in advanced esophageal cancer
ChiCTR2000032829Phase 2Not yet recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cosiporfin sodium in esophageal cancer, sponsored by Peking University Cancer Hospital & Institute. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
cosiporfin sodium
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on ChiCTR2000032829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032829.